ノイルイミューン・バイオテック(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4893/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2025/03/21日証協無担保0株0%0株0%4,001株+5.21%
2025/03/21日証協有担保841,800株-57.32%50,500株0%295,100株+121.33%
2025/03/14日証協無担保0株0%0株0%3,803株-84.56%
2025/03/14日証協有担保1,972,500株+144.12%0株-100%133,333株-20.51%
2025/03/07日証協無担保0株0%0株0%24,624株+251.42%
2025/03/07日証協有担保808,000株+14.14%35,100株+84.74%167,733株+17.02%
2025/02/28日証協無担保0株0%0株0%7,007株-72.67%
2025/02/28日証協有担保707,900株-58.45%19,000株-55.92%143,333株-22.87%
2025/02/21日証協無担保0株-100%0株0%25,642株+113.67%
2025/02/21日証協有担保1,703,900株-30.23%43,100株+108.21%185,833株-6.16%
2025/02/14日証協無担保4,600株0%0株-100%12,001株-90.1%
2025/02/14日証協有担保2,442,100株-47.64%20,700株-93.97%198,033株-55.22%
2025/02/07日証協無担保0株0%100株0%121,203株+339.09%
2025/02/07日証協有担保4,663,700株+415.9%343,100株+9999.99%442,210株+354.95%
2025/01/31日証協無担保0株0%0株0%27,603株+62.81%
2025/01/31日証協有担保904,000株+627.86%2,300株0%97,200株-50.39%
2025/01/24日証協無担保0株0%0株0%16,954株-23.63%
2025/01/24日証協有担保124,200株-89.44%0株-100%195,910株-29.71%
2025/01/17日証協無担保0株0%0株-100%22,201株-56.21%
2025/01/17日証協有担保1,176,200株-53.47%78,100株+123.14%278,700株+30.65%
2025/01/10日証協無担保0株0%100株0%50,701株+624.2%
2025/01/10日証協有担保2,527,700株+5133.33%35,000株+3400%213,310株+210.95%
2024/12/30日証協無担保0株0%0株0%7,001株-96.87%
2024/12/30日証協有担保48,300株-98.62%1,000株-87.34%68,600株-76.39%
2024/12/27日証協無担保0株0%0株0%223,605株+670.97%
2024/12/27日証協有担保3,511,900株+297.86%7,900株-86.09%290,497株+46.78%
2024/12/20日証協無担保0株-100%0株0%29,003株-43.13%
2024/12/20日証協有担保882,700株+512.99%56,800株0%197,910株+478.63%
2024/12/13日証協無担保100株-85.71%0株0%51,003株+118.77%
2024/12/13日証協有担保144,000株-94.02%0株-100%34,203株+123.55%
2024/12/06日証協無担保700株-84.44%0株0%23,313株+124.08%
2024/12/06日証協有担保2,406,100株-43.64%400株0%15,300株-83.71%
2024/11/29日証協無担保4,500株-25%0株0%10,404株-7.33%
2024/11/29日証協有担保4,269,200株+153.56%0株-100%93,900株-64.65%
2024/11/22日証協無担保6,000株+42.86%0株0%11,227株-78.16%
2024/11/22日証協有担保1,683,700株-50.62%10,600株-77.73%265,600株+142.32%
2024/11/15日証協無担保4,200株+133.33%0株-100%51,404株+202.31%
2024/11/15日証協有担保3,409,900株+54.78%47,600株+32.96%109,608株+34.99%

※株式分割は考慮していませんのでご注意ください。

Page Top